Novo Nordisk A/S
NYSE:NVO
Wall Street
Price Targets
NVO Price Targets Summary
Novo Nordisk A/S
According to Wall Street analysts, the average 1-year price target for
NVO
is 133.89 USD
with a low forecast of 77.99 USD and a high forecast of 168.28 USD.
NVO Last Price Targets
Novo Nordisk A/S
The latest public price target was made on Apr 12, 2024 by
Evan David Seigerman
from
BMO Capital
,
who expects
NVO
stock to
rise by 28%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Evan David Seigerman
BMO Capital
|
163
USD
Upside 28% |
2 weeks ago
Apr 12, 2024
|
BMO Capital Starts Novo Nordisk (NVO) at Outperform
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is NVO's stock price target?
Price Target
133.89
USD
According to Wall Street analysts, the average 1-year price target for
NVO
is 133.89 USD
with a low forecast of 77.99 USD and a high forecast of 168.28 USD.
What is Novo Nordisk A/S's Revenue forecast?
Projected CAGR
21%
For the last 8 years the
compound annual growth rate for
Novo Nordisk A/S's revenue is
10%.
The projected
CAGR
for the next 3 years is
21%.
What is Novo Nordisk A/S's Operating Income forecast?
Projected CAGR
22%
For the last 8 years the
compound annual growth rate for
Novo Nordisk A/S's operating income is
11%.
The projected
CAGR
for the next 3 years is
22%.
What is Novo Nordisk A/S's Net Income forecast?
Projected CAGR
23%
For the last 8 years the
compound annual growth rate for
Novo Nordisk A/S's net income is
12%.
The projected
CAGR
for the next 3 years is
23%.
You don't have any saved screeners yet
